Ricky Trigg

3PUBLICATIONS
5CO-AUTHORS
Molecular targetsCancer diagnosisHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 30, 2019
The targetable kinase PIM1 drives ALK inhibitor resistance in high-risk neuroblastoma independent of MYCN status.

Ricky M Trigg, Liam C Lee, Nina Prokoph

|Sep 01, 2018
Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity.

Ni Ni Moe Myint, Ajay M Verma, Daniel Fernandez-Garcia

|Apr 13, 2018
ALK in Neuroblastoma: Biological and Therapeutic Implications.

Ricky M Trigg, Suzanne D Turner

Pageof 1